Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.6%

1 terminated/withdrawn out of 180 trials

Success Rate

96.9%

+10.3% vs industry average

Late-Stage Pipeline

7%

13 trials in Phase 3/4

Results Transparency

0%

0 of 31 completed trials have results

Key Signals

69 recruiting

Enrollment Performance

Analytics

N/A
51(42.9%)
Early Phase 1
23(19.3%)
Phase 2
17(14.3%)
Phase 1
15(12.6%)
Phase 3
7(5.9%)
Phase 4
6(5.0%)
119Total
N/A(51)
Early Phase 1(23)
Phase 2(17)
Phase 1(15)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (180)

Showing 20 of 180 trials
NCT07852598Completed

A Metagenomic Next-generation Sequencing (mNGS)-Guided Sequential Culture Strategy for Postoperative Cruciate Ligament Reconstruction Infection (CLRI): a Retrospective Cohort Study

Role: lead

NCT06737913Phase 2Recruiting

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

Role: collaborator

NCT07837271Active Not Recruiting

Development and External Validation of a Prognostic Model for DFS After Curative Resection of Duodenal GIST

Role: lead

NCT07632131Not ApplicableRecruiting

Preventive Narrative Exposure Intervention for PTSD in ICU Patients After Cardiopulmonary Bypass Cardiac Surgery

Role: lead

NCT07827482Completed

Pretreatment 18F-FDG PET/CT Radiomics for Predicting Response to First-Line Targeted Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma

Role: lead

NCT07818083Phase 3Not Yet Recruiting

The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent

Role: lead

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: collaborator

NCT06763289Active Not Recruiting

Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: cfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection

Role: collaborator

NCT07743866Not ApplicableNot Yet Recruiting

Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3

Role: lead

NCT07790354Phase 3Not Yet Recruiting

APEX-STROKE EAGLE Domain (EAGLE)

Role: collaborator

NCT06990412Not ApplicableCompleted

A Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Wireless Brain-Computer Interface(BCI)System NEO in Patients With Tetraplegia

Role: collaborator

NCT07185373Phase 2Recruiting

Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL

Role: collaborator

NCT07771764Phase 2Not Yet Recruiting

A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung Cancer

Role: lead

NCT07761507Not ApplicableRecruiting

Transcutaneous Auricular Vagus Nerve Stimulation for Recovery of Consciousness After Surgery for Spontaneous Intracerebral Hemorrhage

Role: collaborator

NCT04504526Early Phase 1Recruiting

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Role: lead

NCT05824923Phase 3Active Not Recruiting

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Role: collaborator

NCT05188872Not ApplicableRecruiting

Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE

Role: lead

NCT04499365Early Phase 1Recruiting

68Ga-FAPI PET/CT in Patients With Various Types of Cancer

Role: lead

NCT05975398Recruiting

China Research for Severe Spontaneous Intracerebral Hemorrhage(CRISIH)

Role: collaborator

NCT07682584Not Yet Recruiting

Predictors of BCR After RARP for Localized Prostate Cancer: A Retrospective Analysis

Role: lead